Invention Grant
- Patent Title: Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity
-
Application No.: US14609524Application Date: 2015-01-30
-
Publication No.: US09453013B2Publication Date: 2016-09-27
- Inventor: Fabio Rancati , Ian Linney , Chris Knight , Wolfgang Schmidt
- Applicant: CHIESI FARMACEUTICI S.p.A.
- Applicant Address: IT Parma
- Assignee: CHIESI FARMACEUTICI S.p.A.
- Current Assignee: CHIESI FARMACEUTICI S.p.A.
- Current Assignee Address: IT Parma
- Agency: Oblon, McClelland, Maier & Neustadt, L.L.P.
- Priority: EP12195898 20121206
- Main IPC: C07D453/02
- IPC: C07D453/02 ; A61K31/496 ; A61K31/4709 ; A61K45/06 ; A61M15/00 ; A61M16/14 ; A61K9/00
Abstract:
Compounds of formula (I) defined herein act both as muscarinic receptor antagonists and beta2 adrenergic receptor agonists and are useful for the prevention and/or treatment of broncho-obstructive or inflammatory diseases.
Public/Granted literature
- US20150139916A1 COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY Public/Granted day:2015-05-21
Information query
